Skip to Content
Merck
All Photos(2)

Key Documents

AB1128

Sigma-Aldrich

Anti-Respiratory Syncytial Virus Antibody

Chemicon®, from goat

Synonym(s):

RSV

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

biological source

goat

Quality Level

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

polyclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

ELISA: suitable
immunofluorescence: suitable
immunohistochemistry: suitable (paraffin)

shipped in

wet ice

Specificity

Recognizes RSV, all antigens. Does not react with Para 1-3, Influenza A & B and Adenovirus by IFA. Non reactive with HEp-2 cells and WI-38 cells.

Immunogen

Human RSV isolate

Application

Anti-Respiratory Syncytial Virus Antibody is an antibody against Respiratory Syncytial Virus for use in ELISA, IF, IH(P).
Indirect immunofluorescence: 1:480.

Reactive in paraffin embedded sections (see matsuse, et al 2000).

ELISA: 1:10,000

Fusion inhibition (1:256)

Optimal working dilutions must be determined by end user.

Physical form

Format: Purified
Purified immunoglobulin in PBS (0.01 M, pH 7.2) with 0.1% sodium azide.

Storage and Stability

Maintain -20°C in undiluted aliquots for up to 12 months. Avoid repeated freeze/thaw cycles.

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Weidong Zhang et al.
Nature medicine, 11(1), 56-62 (2004-12-28)
Respiratory syncytial virus (RSV) infection is one of the major causes of respiratory tract infection for which no vaccine or antiviral treatment is available. The RSV NS1 protein seems to antagonize the host interferon (IFN) response; however, its mechanism is
Recombinant simian varicella viruses expressing respiratory syncytial virus antigens are immunogenic.
Ward, TM; Traina-Dorge, V; Davis, KA; Gray, WL
The Journal of General Virology null
Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice.
De Baets, S; Schepens, B; Sedeyn, K; Schotsaert, M; Roose, K; Bogaert, P; Fiers, W; Saelens, X
Journal of virology null
Protein kinase C-alpha activity is required for respiratory syncytial virus fusion to human bronchial epithelial cells.
San-Juan-Vergara, H; Peeples, ME; Lockey, RF; Mohapatra, SS
Journal of virology null
Nanobodies? specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion.
Schepens, B; Iba?ez, LI; De Baets, S; Hultberg, A; Bogaert, P; De Bleser, P; Vervalle et al.
The Journal of Infectious Diseases null

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service